Cryopreserved Embryo Transfer: Endometrial Preparation and Timing

Abstract

The objective of this article was to review and synthesize information from the scientific literature pertaining to the preparation of endometrium for cryopreserved embryo transfer. This article is a critical review of selected scientific literature, synthesis, and formulation of opinion. Estrogen and progesterone are necessary and sufficient to induce endometrial receptivity in cryopreserved embryo transfer cycles. A variety of regimens have been described including natural cycles using endogenous ovarian hormones and artificial or programmed cycles with exogenously administered steroid hormones. To achieve optimal synchrony between embryo and endometrium, the timing of progesterone administration needs to be adjusted to the developmental stage of the thawed embryos. There is currently no evidence that any single regimen or adjuvant substance results in superior outcomes in cryopreserved embryo transfer cycles, although timing of progesterone administration does matter. Although no single regimen of endometrial preparation for cryopreserved embryo transfer has been proven superior to the others, the relative convenience and ease of use do vary, depending on the route of administration chosen and any adjuvant added to the cycle.

Keywords

cryopreserved embryo transfer - frozen embryo transfer - endometrial receptivity - endometrial preparation

• References

• 1 Paulson RJ, Hatch IE, Lobo RA, Sauer MV. Cumulative conception and live birth rates after oocyte donation: implications regarding endometrial receptivity. Hum Reprod 1997; 12 (4) 835-839
• 2 Ghobara T, Vandekerckhove P. Cycle regimens for frozen-thawed embryo transfer. Cochrane Database Syst Rev 2008; (1) CD003414
• 3 Lutjen P, Trounson A, Leeton J, Findlay J, Wood C, Renou P. The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature 1984; 307 (5947) 174-175
• 4 Young JR, Jaffe RB. Strength-duration characteristics of estrogen effects on gonadotropin response to gonadotropin-releasing hormone in women. II. Effects of varying concentrations of estradiol. J Clin Endocrinol Metab 1976; 42 (3) 432-442
• 5 Tourgeman DE, Boostanfar R, Chang L, Lu J, Stanczyk FZ, Paulson RJ. Is there evidence for preferential delivery of ovarian estradiol to the endometrium?. Fertil Steril 2001; 75 (6) 1156-1158
• 6 Navot D, Laufer N, Kopolovic J , et al. Artificially induced endometrial cycles and establishment of pregnancies in the absence of ovaries. N Engl J Med 1986; 314 (13) 806-811
• 7 Rosenwaks Z. Donor eggs: their application in modern reproductive technologies. Fertil Steril 1987; 47 (6) 895-909
• 8 Sauer MV, Paulson RJ. Human oocyte and preembryo donation: an evolving method for the treatment of infertility. Am J Obstet Gynecol 1990; 163 (5, Pt 1) 1421-1424
• 9 Sauer MV, Paulson RJ, Lobo RA. Reversing the natural decline in human fertility. An extended clinical trial of oocyte donation to women of advanced reproductive age. JAMA 1992; 268 (10) 1275-1279
• 10 Kuhnz W, Gansau C, Mahler M. Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17 beta-estradiol. Arzneimittelforschung 1993; 43 (9) 966-973
• 11 Kuhl H. Pharmacokinetics of oestrogens and progestogens. Maturitas 1990; 12 (3) 171-197
• 12 Yen SSC, Martin PL, Burnier AM, Czekala NM, Greaney Jr MO, Callantine MR. Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17β-estradiol in postmenopausal women. J Clin Endocrinol Metab 1975; 40 (3) 518-521
• 13 Chetkowski RJ, Meldrum DR, Steingold KA , et al. Biologic effects of transdermal estradiol. N Engl J Med 1986; 314 (25) 1615-1620
• 14 Krasnow JS, Lessey BA, Naus G, Hall LL, Guzick DS, Berga SL. Comparison of transdermal versus oral estradiol on endometrial receptivity. Fertil Steril 1996; 65 (2) 332-336
• 15 Schiff I, Tulchinsky D, Ryan KJ. Vaginal absorption of estrone and 17beta-estradiol. Fertil Steril 1977; 28 (10) 1063-1066
• 16 Tourgeman DE, Gentzchein E, Stanczyk FZ, Paulson RJ. Serum and tissue hormone levels of vaginally and orally administered estradiol. Am J Obstet Gynecol 1999; 180 (6, Pt 1): 1480-1483
• 17 Fanchin R, Righini C, Schönauer LM, Olivennes F, Cunha Filho JS, Frydman R. Vaginal versus oral E(2) administration: effects on endometrial thickness, uterine perfusion, and contractility. Fertil Steril 2001; 76 (5) 994-998
• 18 Miles RA, Paulson RJ, Lobo RA, Press MF, Dahmoush L, Sauer MV. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil Steril 1994; 62 (3) 485-490
• 19 Cicinelli E, de Ziegler D, Bulletti C, Matteo MG, Schonauer LM, Galantino P. Direct transport of progesterone from vagina to uterus. Obstet Gynecol 2000; 95 (3) 403-406
• 20 Tourgeman DE, Slater CC, Stanczyk FZ, Paulson RJ. Endocrine and clinical effects of micronized estradiol administered vaginally or orally. Fertil Steril 2001; 75 (1) 200-202
• 21 Diamond MP, Kruger M, Santoro N , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Cooperative Reproductive Medicine Network. Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome. Obstet Gynecol 2012; 119 (5) 902-908
• 22 Sauer MV, Stein AL, Paulson RJ, Moyer DL. Endometrial responses to various hormone replacement regimens in ovarian failure patients preparing for embryo donation. Int J Gynaecol Obstet 1991; 35 (1) 61-68
• 23 Sauer MV, Miles RA, Dahmoush L, Paulson RJ, Press M, Moyer D. Evaluating the effect of age on endometrial responsiveness to hormone replacement therapy: a histologic ultrasonographic, and tissue receptor analysis. J Assist Reprod Genet 1993; 10 (1) 47-52
• 24 Hofmann GE, Thie J, Scott Jr RT, Navot D. Endometrial thickness is predictive of histologic endometrial maturation in women undergoing hormone replacement for ovum donation. Fertil Steril 1996; 66 (3) 380-383
• 25 Fritz MA, Speroff LD. Clinical Gynecologic Endocrinology and Infertility. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2011: 128-129
• 26 Garrido-Gómez T, Ruiz-Alonso M, Blesa D, Diaz-Gimeno P, Vilella F, Simón C. Profiling the gene signature of endometrial receptivity: clinical results. Fertil Steril 2013; 99 (4) 1078-1085
• 27 Scotchie JG, Fritz MA, Mocanu M, Lessey BA, Young SL. Proteomic analysis of the luteal endometrial secretome. Reprod Sci 2009; 16 (9) 883-893
• 28 Lessey BA, Castelbaum AJ. Integrins and implantation in the human. Rev Endocr Metab Disord 2002; 3 (2) 107-117
• 29 Albelda SM, Buck CA. Integrins and other cell adhesion molecules. FASEB J 1990; 4 (11) 2868-2880
• 30 Aplin JD. MUC-1 glycosylation in endometrium: possible roles of the apical glycocalyx at implantation. Hum Reprod 1999; 14 (Suppl. 02) 17-25
• 31 DeSouza MM, Surveyor GA, Price RE , et al. MUC1/episialin: a critical barrier in the female reproductive tract. J Reprod Immunol 1999; 45 (2) 127-158
• 32 Surveyor GA, Gendler SJ, Pemberton L, Spicer AP, Carson DD. Differential expression of Muc-1 at the apical cell surface of mouse uterine epithelial cells. FASEB J 1993; 7: 1151a
• 33 Aplin JD, Hey NA, Graham RA. Human endometrial MUC1 carries keratan sulfate: characteristic glycoforms in the luminal epithelium at receptivity. Glycobiology 1998; 8 (3) 269-276
• 34 Carson DD, DeSouza MM, Regisford EGC. Mucin and proteoglycan functions in embryo implantation. BioEssays 1998; 20 (7) 577-583
• 35 Carson DD, Julian J, Lessey BA, Prakobphol A, Fisher SJ. MUC1 is a scaffold for selectin ligands in the human uterus. Front Biosci 2006; 11: 2903-2908
• 36 Fukuda MN, Sato T, Nakayama J , et al. Trophinin and tastin, a novel cell adhesion molecule complex with potential involvement in embryo implantation. Genes Dev 1995; 9 (10) 1199-1210
• 37 Margarit L, Gonzalez D, Lewis PD , et al. L-selectin ligands in human endometrium: comparison of fertile and infertile subjects. Hum Reprod 2009; 24 (11) 2767-2777
• 38 Wang B, Sheng JZ, He RH, Qian YL, Jin F, Huang HF. High expression of L-selectin ligand in secretory endometrium is associated with better endometrial receptivity and facilitates embryo implantation in human being. Am J Reprod Immunol 2008; 60 (2) 127-134
• 39 Foulk RA, Zdravkovic T, Genbacev O, Prakobphol A. Expression of L-selectin ligand MECA-79 as a predictive marker of human uterine receptivity. J Assist Reprod Genet 2007; 24 (7) 316-321
• 40 Lai TH, Shih IeM, Vlahos N, Ho CL, Wallach E, Zhao Y. Differential expression of L-selectin ligand in the endometrium during the menstrual cycle. Fertil Steril 2005; 83 (Suppl. 01) 1297-1302
• 41 Aghajanova L, Bjuresten K, Altmäe S, Landgren BM, Stavreus-Evers A. HB-EGF but not amphiregulin or their receptors HER1 and HER4 is altered in endometrium of women with unexplained infertility. Reprod Sci 2008; 15 (5) 484-492
• 42 Lessey BA, Gui Y, Apparao KB, Young SL, Mulholland J. Regulated expression of heparin-binding EGF-like growth factor (HB-EGF) in the human endometrium: a potential paracrine role during implantation. Mol Reprod Dev 2002; 62 (4) 446-455
• 43 Kimber SJ. Molecular interactions at the maternal-embryonic interface during the early phase of implantation. Semin Reprod Med 2000; 18 (3) 237-253
• 44 Iwamoto R, Mekada E. Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev 2000; 11 (4) 335-344
• 45 Filicori M, Butler JP, Crowley Jr WF. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. J Clin Invest 1984; 73 (6) 1638-1647
• 46 Usadi RS, Groll JM, Lessey BA , et al. Endometrial development and function in experimentally induced luteal phase deficiency. J Clin Endocrinol Metab 2008; 93 (10) 4058-4064
• 47 Young SL, Lessey BA, Balthazar U , et al. Defining the relationship between progesterone dose, endometrial histology and gene expression using an in vivo luteal phase defect model. Reprod Sci 2011; 18 (4S): 273A
• 48 Bourgain C, Devroey P, Van Waesberghe L, Smitz J, Van Steirteghem AC. Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Hum Reprod 1990; 5 (5) 537-543
• 49 Cicinelli E, Ragno G, Cagnazzo I, Fanelli F, Vetuschi C, Schonauer S. Progesterone administration by nasal spray. Fertil Steril 1991; 56 (1) 139-141
• 50 Nillius SJ, Johansson ED. Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone. Am J Obstet Gynecol 1971; 110 (4) 470-477
• 51 Chakmakjian ZH, Zachariah NY. Bioavailability of progesterone with different modes of administration. J Reprod Med 1987; 32 (6) 443-448
• 52 Nikas G, Drakakis P, Loutradis D , et al. Uterine pinopodes as markers of the ‘nidation window’ in cycling women receiving exogenous oestradiol and progesterone. Hum Reprod 1995; 10 (5) 1208-1213
• 53 Nikas G, Psychoyos A. Uterine pinopodes in peri-implantation human endometrium. Clinical relevance. Ann N Y Acad Sci 1997; 816: 129-142
• 54 Mishell Jr DR, Nakamura RM, Crosignani PG , et al. Serum gonadotropin and steroid patterns during the normal menstrual cycle. Am J Obstet Gynecol 1971; 111 (1) 60-65
• 55 Navot D, Scott RT, Droesch K, Veeck LL, Liu HC, Rosenwaks Z. The window of embryo transfer and the efficiency of human conception in vitro. Fertil Steril 1991; 55 (1) 114-118
• 56 Navot D, Bergh PA, Williams M , et al. An insight into early reproductive processes through the in vivo model of ovum donation. J Clin Endocrinol Metab 1991; 72 (2) 408-414
• 57 Lelaidier C, de Ziegler D, Freitas S, Olivennes F, Hazout A, Frydman R. Endometrium preparation with exogenous estradiol and progesterone for the transfer of cryopreserved blastocysts. Fertil Steril 1995; 63 (4) 919-921
• 58 Prapas Y, Prapas N, Jones EE , et al. The window for embryo transfer in oocyte donation cycles depends on the duration of progesterone therapy. Hum Reprod 1998; 13 (3) 720-723
• 59 Glujovsky D, Pesce R, Fiszbajn G, Sueldo C, Hart RJ, Ciapponi A. Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes. Cochrane Database Syst Rev 2010; (1) CD006359
• 60 Fritz MA, Westfahl PK, Graham RL. The effect of luteal phase estrogen antagonism on endometrial development and luteal function in women. J Clin Endocrinol Metab 1987; 65 (5) 1006-1013
• 61 de Ziegler D, Bergeron C, Cornel C , et al. Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins. J Clin Endocrinol Metab 1992; 74 (2) 322-331
• 62 Younis JS, Ezra Y, Sherman Y, Simon A, Schenker JG, Laufer N. The effect of estradiol depletion during the luteal phase on endometrial development. Fertil Steril 1994; 62 (1) 103-107
• 63 Groll JM, Usadi RS, Lessey BA, Lininger R, Young SL, Fritz MA. Effects of variations in serum estradiol concentrations on secretory endometrial development and function in experimentally induced cycles in normal women. Fertil Steril 2009; 92 (6) 2058-2061
• 64 Gonen Y, Casper RF. Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization (IVF). J In Vitro Fert Embryo Transf 1990; 7 (3) 146-152
• 65 Noyes N, Liu HC, Sultan K, Schattman G, Rosenwaks Z. Endometrial thickness appears to be a significant factor in embryo implantation in in-vitro fertilization. Hum Reprod 1995; 10 (4) 919-922
• 66 Abdalla HI, Brooks AA, Johnson MR, Kirkland A, Thomas A, Studd JW. Endometrial thickness: a predictor of implantation in ovum recipients?. Hum Reprod 1994; 9 (2) 363-365
• 67 Remohí J, Ardiles G, García-Velasco JA, Gaitán P, Simón C, Pellicer A. Endometrial thickness and serum oestradiol concentrations as predictors of outcome in oocyte donation. Hum Reprod 1997; 12 (10) 2271-2276
• 68 El-Toukhy T, Taylor A, Khalaf Y , et al. Pituitary suppression in ultrasound-monitored frozen embryo replacement cycles. A randomised study. Hum Reprod 2004; 19 (4) 874-879
• 69 Jimenez PT, Schon SB, Odem RR, Ratts VS, Jungheim ES. A retrospective cross-sectional study: fresh cycle endometrial thickness is a sensitive predictor of inadequate endometrial thickness in frozen embryo transfer cycles. Reprod Biol Endocrinol 2013; 11: 35
• 70 Kasius A, Smit JG, Torrance HL , et al. Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Hum Reprod Update 2014; 20 (4) 530-541
• 71 Amui J, Check JH, Cohen R. Successful twin pregnancy in a donor oocyte recipient despite a maximum endometrial thickness in the late proliferative phase of 4 mm. Clin Exp Obstet Gynecol 2011; 38 (4) 328-329
• 72 Dix E, Check JH. Successful pregnancies following embryo transfer despite very thin late proliferative endometrium. Clin Exp Obstet Gynecol 2010; 37 (1) 15-16
• 73 Liao X, Li Z, Dong X, Zhang H. Comparison between oral and vaginal estrogen usage in inadequate endometrial patients for frozen-thawed blastocysts transfer. Int J Clin Exp Pathol 2014; 7 (10) 6992-6997
• 74 Wada I, Hsu CC, Williams G, Macnamee MC, Brinsden PR. The benefits of low-dose aspirin therapy in women with impaired uterine perfusion during assisted conception. Hum Reprod 1994; 9 (10) 1954-1957
• 75 Weckstein LN, Jacobson A, Galen D, Hampton K, Hammel J. Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study. Fertil Steril 1997; 68 (5) 927-930
• 76 Dal Prato L, Borini A, Cattoli M, Bonu MA, Sciajno R, Flamigni C. Endometrial preparation for frozen-thawed embryo transfer with or without pretreatment with gonadotropin-releasing hormone agonist. Fertil Steril 2002; 77 (5) 956-960
• 77 Ramos J, Caligara C, Tocino A, Rodriguez I, Carranza F, Fernandez-Sanchez M. Prospective randomized study to compare frozen thawed embryo transfer cycles outcomes in women with functioning ovaries and HRT for endometrium preparation with or without prior GnRH suppression. Washington, DC, ASRM Annual Meeting; 2007
• 78 Tesarik J, Hazout A, Mendoza C. Luteinizing hormone affects uterine receptivity independently of ovarian function. Reprod Biomed Online 2003; 7 (1) 59-64
• 79 Ben-Meir A, Aboo-Dia M, Revel A, Eizenman E, Laufer N, Simon A. The benefit of human chorionic gonadotropin supplementation throughout the secretory phase of frozen-thawed embryo transfer cycles. Fertil Steril 2010; 93 (2) 351-354
• 80 Eftekhar M, Rahmani E, Eftekhar T. Effect of adding human chorionic gonadotropin to the endometrial preparation protocol in frozen embryo transfer cycles. Int J Fertil Steril 2012; 6 (3) 175-178
• 81 Papanikolaou EG, Kyrou D, Zervakakou G, Paggou E, Humaidan P. Follicular HCG endometrium priming for IVF patients experiencing resisting thin endometrium. A proof of concept study. J Assist Reprod Genet 2013; 30 (10) 1341-1345
• 82 Sher G, Fisch JD. Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Hum Reprod 2000; 15 (4) 806-809
• 83 Dehghani Firouzabadi R, Davar R, Hojjat F, Mahdavi M. Effect of sildenafil citrate on endometrial preparation and outcome of frozen-thawed embryo transfer cycles: a randomized clinical trial. Iran J Reprod Med 2013; 11 (2) 151-158
• 84 Nakagawa K, Ojiro Y, Jyuen H , et al. Prostaglandin therapy during the proliferative phase improves pregnancy rates following frozen embryo transfer in a hormone replacement cycle. J Obstet Gynaecol Res 2014; 40 (5) 1331-1337
• 85 Barash A, Dekel N, Fieldust S, Segal I, Schechtman E, Granot I. Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization. Fertil Steril 2003; 79 (6) 1317-1322
• 86 Zhou L, Li R, Wang R, Huang HX, Zhong K. Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates. Fertil Steril 2008; 89 (5) 1166-1176
• 87 Gnainsky Y, Granot I, Aldo PB , et al. Local injury of the endometrium induces an inflammatory response that promotes successful implantation. Fertil Steril 2010; 94 (6) 2030-2036
• 88 Dunne C, Taylor B. Does endometrial injury improve implantation of frozen-thawed embryos?. Arch Gynecol Obstet 2014; 290 (3) 575-579
• 89 Marrs RP, Brown J, Sato F , et al. Successful pregnancies from cryopreserved human embryos produced by in vitro fertilization. Am J Obstet Gynecol 1987; 156 (6) 1503-1508
• 90 Wright KP, Guibert J, Weitzen S, Davy C, Fauque P, Olivennes F. Artificial versus stimulated cycles for endometrial preparation prior to frozen-thawed embryo transfer. Reprod Biomed Online 2006; 13 (3) 321-325
• 91 Levron J, Yerushalmi GM, Brengauz M, Gat I, Katorza E. Comparison between two protocols for thawed embryo transfer: natural cycle versus exogenous hormone replacement. Gynecol Endocrinol 2014; 30 (7) 494-497
• 92 Veleva Z, Orava M, Nuojua-Huttunen S, Tapanainen JS, Martikainen H. Factors affecting the outcome of frozen-thawed embryo transfer. Hum Reprod 2013; 28 (9) 2425-2431
• 93 Kyrou D, Fatemi HM, Blockeel C , et al. Transfer of cryopreserved - thawed embryos in hCG induced natural or clomiphene citrate cycles yields similar live birth rates in normo-ovulatory women. J Assist Reprod Genet 2010; 27 (12) 683-689
• 94 Wagman I, Levin I, Kapustiansky R , et al. Clomiphene citrate vs. letrozole for cryopreserved-thawed embryo transfer: a randomized, controlled trial. J Reprod Med 2010; 55 (3-4) 134-138